Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation

Updated June 19th, 2020

Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation

NOW
PLAYING
The Current and Future Role of Immunotherapy in Bladder Cancer
NOW
PLAYING
For Newly Diagnosed Multiple Myeloma Patients-- The New Four Drug Combination Showing Unprecedented Results
NOW
PLAYING
New Hope For Stomach Cancer: Immunotherapy Drug Opdivo Now Approved As a First Treatment
NOW
PLAYING
All About Acute Lymphoblastic Leukemia
NOW
PLAYING
Some Melanoma Survivors See Long-Term Side Effects After Immunotherapy, Says New Study
NOW
PLAYING
FDA Approves Lorlatinib to Treat Some Cases of Lung Cancer

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.